Log in

Relevant bibliographies by topics / Usher syndrome type 1J / Journal articles

Journal articles on the topic 'Usher syndrome type 1J'

To see the other types of publications on this topic, follow the link: Usher syndrome type 1J.

Author: Grafiati

Published: 11 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Usher syndrome type 1J.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Riazuddin, Saima, Inna A. Belyantseva, Arnaud P. J. Giese, Kwanghyuk Lee, Artur A. Indzhykulian, Sri Pratima Nandamuri, Rizwan Yousaf, et al. "Alterations of the CIB2 calcium- and integrin-binding protein cause Usher syndrome type 1J and nonsyndromic deafness DFNB48." Nature Genetics 44, no. 11 (September 30, 2012): 1265–71. http://dx.doi.org/10.1038/ng.2426.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Jan, A. "Mutations in CIB2 calcium and integrin-binding protein disrupt auditory hair cell calcium homeostasis in Usher syndrome type 1J and non-syndromic deafnessDFNB48." Clinical Genetics 83, no. 4 (April 2013): 317–18. http://dx.doi.org/10.1111/cge.12100.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Castiglione, Alessandro, and Claes Möller. "Usher Syndrome." Audiology Research 12, no. 1 (January 11, 2022): 42–65. http://dx.doi.org/10.3390/audiolres12010005.

Full text

Abstract:

Usher syndrome (USH) is the most common genetic condition responsible for combined loss of hearing and vision. Balance disorders and bilateral vestibular areflexia are also observed in some cases. The syndrome was first described by Albrecht von Graefe in 1858, but later named by Charles Usher, who presented a large number of cases with hearing loss and retinopathy in 1914. USH has been grouped into three main clinical types: 1, 2, and 3, which are caused by mutations in different genes and are further divided into different subtypes. To date, nine causative genes have been identified and confirmed as responsible for the syndrome when mutated: MYO7A, USH1C, CDH23, PCDH15, and USH1G (SANS) for Usher type 1; USH2A, ADGRV1, and WHRN for Usher type 2; CLRN1 for Usher type 3. USH is inherited in an autosomal recessive pattern. Digenic, bi-allelic, and polygenic forms have also been reported, in addition to dominant or nonsyndromic forms of genetic mutations. This narrative review reports the causative forms, diagnosis, prognosis, epidemiology, rehabilitation, research, and new treatments of USH.

APA, Harvard, Vancouver, ISO, and other styles

4

Pennings, Ronald J. E., August F. Deutman, Randall R. Fields, William J. Kimberling, Patrick L. M. Huygen, and W. R. J. Cremers. "Usher Syndrome Type III Can Mimic other Types of Usher Syndrome." Annals of Otology, Rhinology & Laryngology 112, no. 6 (June 2003): 525–30. http://dx.doi.org/10.1177/000348940311200608.

Full text

Abstract:

Clinical and genetic characteristics are presented of 2 patients from a Dutch Usher syndrome type III family who have a new homozygous USH3 gene mutation: 149–152delCAGG + insTGTCCAAT. One individual (IV: 1) is profoundly hearing impaired and has normal vestibular function and retinitis punctata albescens (RPA). The other individual is also profoundly hearing impaired, but has well-developed speech, vestibular areflexia, and retinitis pigmentosa sine pigmento (RPSP). These findings suggest that Usher syndrome type III can be clinically misdiagnosed as either Usher type I or II; that Usher syndrome patients who are profoundly hearing impaired and have normal vestibular function should be tested for USH3 mutations; and that RPA and RPSP can occur as fundoscopic manifestations of pigmentary retinopathy in Usher syndrome.

APA, Harvard, Vancouver, ISO, and other styles

5

Reisser, Christoph F. V., William J. Kimberling, and Christian R. Otterstedde. "Hearing Loss in Usher Syndrome Type II is Nonprogressive." Annals of Otology, Rhinology & Laryngology 111, no. 12 (December 2002): 1108–11. http://dx.doi.org/10.1177/000348940211101208.

Full text

Abstract:

Usher syndrome is an autosomal recessive disorder characterized by sensorineural hearing loss and progressive visual loss secondary to retinitis pigmentosa. In the literature, a possible progression of the moderate to severe hearing loss in Usher syndrome type II (Usher II) is controversial. We studied the development of the hearing loss of 125 patients with a clinical diagnosis of Usher syndrome type II intraindividually and interindividually by repeatedly performing complete audiological and neuro-otologic examinations. Our data show a very characteristic slope of the hearing curve in all Usher II patients and no clinically relevant progression of the hearing loss over up to 17 years. The subjective impression of a deterioration of the communicative abilities of Usher II patients must therefore be attributed to the progressive visual loss. The patients should be reassured that changes in their hearing abilities are unlikely and should be provided with optimally fitted modern hearing aids.

APA, Harvard, Vancouver, ISO, and other styles

6

Keats, Bronya J. B., Alexander A. Todorov, Larry D. Atwood, Mary Z. Pelias, J. Fielding Hejtmancik, William J. Kimberling, Mark Leppert, Richard A. Lewis, and Richard J. H. Smith. "Linkage studies of usher syndrome type 1: Exclusion results from the usher syndrome consortium." Genomics 14, no. 3 (November 1992): 707–14. http://dx.doi.org/10.1016/s0888-7543(05)80172-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Ouyang, Xiao Mei, Denise Yan, Li Lin Du, J. Fielding Hejtmancik, Samuel G. Jacobson, Walter E. Nance, An Ren Li, et al. "Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient population." Human Genetics 116, no. 4 (January 20, 2005): 292–99. http://dx.doi.org/10.1007/s00439-004-1227-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Aarem, Annelies Van, Mariette Wagenaar, Alfred J. L. G. Pinckers, Patrick L. M. Huygen, Elisabeth M. Bleeker-wagemakers, Bill J. Kimberling, and W. R. J. Cremers. "Ophthalmologic findings in Usher syndrome type 2A." Ophthalmic Genetics 16, no. 4 (January 1995): 151–58. http://dx.doi.org/10.3109/13816819509057856.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Ouyang, XM, D. Yam, JF Hejtmancik, SG Jacobson, AR Li, LL Du, S. Angeli, M. Kaiser, T. Balkany, and XZ Liu. "Mutational spectrum in Usher syndrome type II." Clinical Genetics 65, no. 4 (February 16, 2004): 288–93. http://dx.doi.org/10.1046/j.1399-0004.2004.00216.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Pieke Dahl, S., W. J. Kimberling, M. B. Gorin, M. D. Weston, J. M. Furman, A. Pikus, and C. Moller. "Genetic heterogeneity of Usher syndrome type II." Journal of Medical Genetics 30, no. 10 (October 1, 1993): 843–48. http://dx.doi.org/10.1136/jmg.30.10.843.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Yang, Jun. "Current understanding of usher syndrome type II." Frontiers in Bioscience 17, no. 1 (2012): 1165. http://dx.doi.org/10.2741/3979.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

FRIEDMAN, THOMAS B., JULIE M. SCHULTZ, and ZUBAIR M. AHMED. "Usher Syndrome Type 1: Genotype–Phenotype Relationships." Retina 25, Supplement (December 2005): S40—S42. http://dx.doi.org/10.1097/00006982-200512001-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Toms, Maria, Waheeda Pagarkar, and Mariya Moosajee. "Usher syndrome: clinical features, molecular genetics and advancing therapeutics." Therapeutic Advances in Ophthalmology 12 (January 2020): 251584142095219. http://dx.doi.org/10.1177/2515841420952194.

Full text

Abstract:

Usher syndrome has three subtypes, each being clinically and genetically heterogeneous characterised by sensorineural hearing loss and retinitis pigmentosa (RP), with or without vestibular dysfunction. It is the most common cause of deaf–blindness worldwide with a prevalence of between 4 and 17 in 100 000. To date, 10 causative genes have been identified for Usher syndrome, with MYO7A accounting for >50% of type 1 and USH2A contributing to approximately 80% of type 2 Usher syndrome. Variants in these genes can also cause non-syndromic RP and deafness. Genotype–phenotype correlations have been described for several of the Usher genes. Hearing loss is managed with hearing aids and cochlear implants, which has made a significant improvement in quality of life for patients. While there is currently no available approved treatment for the RP, various therapeutic strategies are in development or in clinical trials for Usher syndrome, including gene replacement, gene editing, antisense oligonucleotides and small molecule drugs.

APA, Harvard, Vancouver, ISO, and other styles

14

Astuto, Lisa M., Michael D. Weston, Carol A. Carney, Denise M. Hoover, Cor W. R. J. Cremers, Mariette Wagenaar, Claes Moller, et al. "Genetic Heterogeneity of Usher Syndrome: Analysis of 151 Families with Usher Type I." American Journal of Human Genetics 67, no. 6 (December 2000): 1569–74. http://dx.doi.org/10.1086/316889.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Zaw, Khine, Livia S. Carvalho, May T. Aung-Htut, Sue Fletcher, Steve D. Wilton, Fred K. Chen, and Samuel McLenachan. "Pathogenesis and Treatment of Usher Syndrome Type IIA." Asia-Pacific Journal of Ophthalmology 11, no. 4 (July 2022): 369–79. http://dx.doi.org/10.1097/apo.0000000000000546.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Rani, Alka, Nikhil Pal, Raj Vardhan Azad, Yog Raj Sharma, Parijat Chandra, and Deependra Vikram Singh. "Tractional retinal detachment in Usher syndrome type II." Clinical and Experimental Ophthalmology 33, no. 4 (August 2005): 436–37. http://dx.doi.org/10.1111/j.1442-9071.2005.01014.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Plantinga, Rutger F., Ronald J. E. Pennings, Patrick L. M. Huygen, Eeva-Marja Sankila, Kaija Tuppurainen, Leenamaija Kleemola, Cor W. R. J. Cremers, and August F. Deutman. "Visual impairment in Finnish Usher syndrome type III." Acta Ophthalmologica Scandinavica 84, no. 1 (December 2, 2005): 36–41. http://dx.doi.org/10.1111/j.1600-0420.2005.00507.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Bujakowska, K. M., M. Consugar, E. Place, S. Harper, J. Lena, D. G. Taub, J. White, et al. "Targeted Exon Sequencing in Usher Syndrome Type I." Investigative Ophthalmology & Visual Science 55, no. 12 (December 2, 2014): 8488–96. http://dx.doi.org/10.1167/iovs.14-15169.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

van Aarem, A., M. Wagenaar, E. Tonnaer, S. Pieke Dahl, J. Bisseling, H. Janssen, B. Bastiaans, W. Kimberling, and C. Cremers. "Semen Analysis in the Usher Syndrome Type 2A." ORL 61, no. 3 (1999): 126–30. http://dx.doi.org/10.1159/000027656.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

CAHILL, MARK T., PETER J. BARRY, and PAUL F. KENNA. "GIANT RETINAL TEAR IN USHER SYNDROME TYPE II." Retina 18, no. 2 (1998): 177. http://dx.doi.org/10.1097/00006982-199818020-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Kıratlı, Hayyam, and Cem Öztürkmen. "Coats-like lesions in Usher syndrome type II." Graefe's Archive for Clinical and Experimental Ophthalmology 242, no. 3 (December 3, 2003): 265–67. http://dx.doi.org/10.1007/s00417-003-0818-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Pakarinen, Leenamaija, Kaija Tuppurainen, Pekka Laippala, Maija M�ntyj�rvi, and Heikki Puhakka. "The ophthalmological course of Usher syndrome type III." International Ophthalmology 19, no. 5 (1995): 307–11. http://dx.doi.org/10.1007/bf00130927.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Baghdadi, Moetez, Simona Caldani, Audrey Maudoux, Isabelle Audo, Maria Pia Bucci, and Sylvette R. Wiener-Vacher. "Subjective visual vertical in patients with Usher syndrome." Journal of Vestibular Research 30, no. 4 (October 17, 2020): 275–82. http://dx.doi.org/10.3233/ves-200711.

Full text

Abstract:

Highlights • The estimation of verticality (assessed with Subjective visual vertical (SVV)) is more variable in patients with Usher (type I and II) compared to healthy participants. • Visual and vestibular information are essential for the visual vertical (VV) perception. • A reweighting of sensory information from the central nervous system seems to be able to compensate for the absence of vestibular function in patients with Usher type I.

APA, Harvard, Vancouver, ISO, and other styles

24

Sahu, Sabin, and Sanjay Kumar Singh. "Usher syndrome Type I in an adult Nepalese male: a rare case report." Nepalese Journal of Ophthalmology 9, no. 2 (February 21, 2018): 203–5. http://dx.doi.org/10.3126/nepjoph.v9i2.19271.

Full text

Abstract:

Usher syndrome, also known as retinitis pigmentosa-dysacusis syndrome, is an extremely rare genetic disorder, characterized by retinitis pigmentosa (RP) and congenital sensorineural hearing loss. It has been estimated to account for 3-6% of the congenitally deaf population, upto 8-33% of individuals with RP and half of all cases with combined deafness and blindness (Vernon M,1969; Boughman JA et al,1983). The prevalence of Usher syndrome have been reported to range from 3.5 to 6.2 per 100,000 in different populations (Vernon M,1969; Boughman JA et al,1983; Yan D et al, 2010).We report a case of Usher syndrome type I in an adult Nepalese male with typical congenital profound hearing loss, and night blindness secondary to retinitis pigmentosa.

APA, Harvard, Vancouver, ISO, and other styles

25

Kim, Joon Hyung, So Ra Bang, Jin Gu Jeong, and Nam Chun Cho. "Type III Usher Syndrome in the Republic of Korea." Journal of the Korean Ophthalmological Society 61, no. 4 (April 15, 2020): 444–48. http://dx.doi.org/10.3341/jkos.2020.61.4.444.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Iwasaki, Satoshi, Hidekane Yoshimura, Norito Takeichi, Hiroaki Satou, Kotaro Ishikawa, Kimitaka Kaga, Kozou Kumakawa, et al. "Problem and Assignment for Distinguishing the Usher Syndrome Type." Nippon Jibiinkoka Gakkai Kaiho 115, no. 10 (2012): 894–901. http://dx.doi.org/10.3950/jibiinkoka.115.894.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Fu, Qing, Mingchu Xu, Xue Chen, Xunlun Sheng, Zhisheng Yuan, Yani Liu, Huajin Li, et al. "CEP78is mutated in a distinct type of Usher syndrome." Journal of Medical Genetics 54, no. 3 (September 14, 2016): 190–95. http://dx.doi.org/10.1136/jmedgenet-2016-104166.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Cockey, Carolyn Davis. "Early Diagnosis of Usher Syndrome Type 1 Now Possible." AWHONN Lifelines 7, no. 4 (August 2003): 314. http://dx.doi.org/10.1111/j.1552-6356.2003.tb00117.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

FARKAS, A., B. LESCH, B. VARSANYI, and R. VA'MOS. "Phenotype characteristics of patients with Usher syndrome type 2." Acta Ophthalmologica Scandinavica 85 (October 2, 2007): 0. http://dx.doi.org/10.1111/j.1600-0420.2007.01062_3240.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Ebermann, I., M. H. J. Wiesen, E. Zrenner, I. Lopez, R. Pigeon, S. Kohl, H. Lowenheim, R. K. Koenekoop, and H. J. Bolz. "GPR98 mutations cause Usher syndrome type 2 in males." Journal of Medical Genetics 46, no. 4 (April 1, 2009): 277–80. http://dx.doi.org/10.1136/jmg.2008.059626.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Miner, I. D. "People with Usher Syndrome, Type II: Issues and Adaptations." Journal of Visual Impairment & Blindness 91, no. 6 (November 1997): 579–89. http://dx.doi.org/10.1177/0145482x9709100610.

Full text

Abstract:

People with Usher syndrome, Type II, were born hard-of-hearing and undergo the progressive loss of vision from adolescence onward—changes that require multiple adaptations. This article describes what they experience in childhood, adolescence, and adulthood; discusses the lack of appropriate services and the failure of professionals to provide sufficient information on the condition; and stresses the importance of access to information and the acquisition of new skills as early as possible before the visual impairment becomes severe.

APA, Harvard, Vancouver, ISO, and other styles

32

Liu, Xue Z., Simon I. Angeli, Kaukab Rajput, Denise Yan, Annelle V. Hodges, Adrien Eshraghi, Fred F. Telischi, and Thomas J. Balkany. "Cochlear implantation in individuals with Usher type 1 syndrome." International Journal of Pediatric Otorhinolaryngology 72, no. 6 (June 2008): 841–47. http://dx.doi.org/10.1016/j.ijporl.2008.02.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Flores-Guevara, Roberto, Francis Renault, Natalie Loundon, Sandrine Marlin, Béatrice Pelosse, Martha Momtchilova, Monique Auzoux-Chevé, Anne Isabelle Vermersch, and Pascal Richard. "Usher syndrome type 1: Early detection of electroretinographic changes." European Journal of Paediatric Neurology 13, no. 6 (November 2009): 505–7. http://dx.doi.org/10.1016/j.ejpn.2008.10.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Kimberling, William J., Michael D. Weston, Claes Möller, Sandra L. H. Davenport, Yin Y. Shugart, Ira A. Priluck, Alessandro Martini, Massimo Milani, and Richard J. Smith. "Localization of Usher syndrome type II to chromosome 1q." Genomics 7, no. 2 (June 1990): 245–49. http://dx.doi.org/10.1016/0888-7543(90)90546-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Sun, John C., Adriaan M. van Alphen, Mariette Wagenaar, Patrick Huygen, Casper C. Hoogenraad, Tama Hasson, Sebastiaan K. E. Koekkoek, Barbara A. Bohne, and Chris I. De Zeeuw. "Origin of Vestibular Dysfunction in Usher Syndrome Type 1B." Neurobiology of Disease 8, no. 1 (February 2001): 69–77. http://dx.doi.org/10.1006/nbdi.2000.0358.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Tosi, Gian Marco. "Usher Syndrome Type 1 Associated With Primary Ciliary Aplasia." Archives of Ophthalmology 121, no. 3 (March 1, 2003): 407. http://dx.doi.org/10.1001/archopht.121.3.407.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Millán, José M., Elena Aller, Teresa Jaijo, Fiona Blanco-Kelly, Ascensión Gimenez-Pardo, and Carmen Ayuso. "An Update on the Genetics of Usher Syndrome." Journal of Ophthalmology 2011 (2011): 1–8. http://dx.doi.org/10.1155/2011/417217.

Full text

Abstract:

Usher syndrome (USH) is an autosomal recessive disease characterized by hearing loss, retinitis pigmentosa (RP), and, in some cases, vestibular dysfunction. It is clinically and genetically heterogeneous and is the most common cause underlying deafness and blindness of genetic origin. Clinically, USH is divided into three types. Usher type I (USH1) is the most severe form and is characterized by severe to profound congenital deafness, vestibular areflexia, and prepubertal onset of progressive RP. Type II (USH2) displays moderate to severe hearing loss, absence of vestibular dysfunction, and later onset of retinal degeneration. Type III (USH3) shows progressive postlingual hearing loss, variable onset of RP, and variable vestibular response. To date, five USH1 genes have been identified:MYO7A(USH1B),CDH23(USH1D),PCDH15(USH1F),USH1C(USH1C), andUSH1G(USH1G). Three genes are involved in USH2, namely,USH2A(USH2A),GPR98(USH2C), andDFNB31(USH2D). USH3 is rare except in certain populations, and the gene responsible for this type isUSH3A.

APA, Harvard, Vancouver, ISO, and other styles

38

Mansard, Luke, David Baux, Christel Vaché, Catherine Blanchet, Isabelle Meunier, Marjolaine Willems, Valérie Faugère, et al. "The Study of a 231 French Patient Cohort Significantly Extends the Mutational Spectrum of the Two Major Usher Genes MYO7A and USH2A." International Journal of Molecular Sciences 22, no. 24 (December 10, 2021): 13294. http://dx.doi.org/10.3390/ijms222413294.

Full text

Abstract:

Usher syndrome is an autosomal recessive disorder characterized by congenital hearing loss combined with retinitis pigmentosa, and in some cases, vestibular areflexia. Three clinical subtypes are distinguished, and MYO7A and USH2A represent the two major causal genes involved in Usher type I, the most severe form, and type II, the most frequent form, respectively. Massively parallel sequencing was performed on a cohort of patients in the context of a molecular diagnosis to confirm clinical suspicion of Usher syndrome. We report here 231 pathogenic MYO7A and USH2A genotypes identified in 73 Usher type I and 158 Usher type II patients. Furthermore, we present the ACMG classification of the variants, which comprise all types. Among them, 68 have not been previously reported in the literature, including 12 missense and 16 splice variants. We also report a new deep intronic variant in USH2A. Despite the important number of molecular studies published on these two genes, we show that during the course of routine genetic diagnosis, undescribed variants continue to be identified at a high rate. This is particularly pertinent in the current era, where therapeutic strategies based on DNA or RNA technologies are being developed.

APA, Harvard, Vancouver, ISO, and other styles

39

Colombo, L., B. Sala, G. Montesano, C. Pierrottet, S. De Cillà, P. Maltese, M. Bertelli, and L. Rossetti. "Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT." Journal of Ophthalmology 2015 (2015): 1–6. http://dx.doi.org/10.1155/2015/189140.

Full text

Abstract:

To portray Usher Syndrome type 2, analyzing choroidal thickness and comparing data reported in published literature on RP and healthy subjects.Methods. 20 eyes of 10 patients with clinical signs and genetic diagnosis of Usher Syndrome type 2. Each patient underwent a complete ophthalmologic examination including Best Corrected Visual Acuity (BCVA), intraocular pressure (IOP), axial length (AL), automated visual field (VF), and EDI OCT. Both retinal and choroidal measures were measured. Statistical analysis was performed to correlate choroidal thickness with age, BCVA, IOP, AL, VF, and RT. Comparison with data about healthy people and nonsyndromic RP patients was performed.Results. Mean subfoveal choroidal thickness (SFCT) was248.21±79.88microns. SFCT was statistically significant correlated with age (correlation coefficient −0.7248179,p<0.01). No statistically significant correlation was found between SFCT and BCVA, IOP, AL, VF, and RT. SFCT was reduced if compared to healthy subjects (p<0.01). No difference was found when compared to choroidal thickness from nonsyndromic RP patients (p=0.2138).Conclusions. Our study demonstrated in vivo choroidal thickness reduction in patients with Usher Syndrome type 2. These data are important for the comprehension of mechanisms of disease and for the evaluation of therapeutic approaches.

APA, Harvard, Vancouver, ISO, and other styles

40

Nakanishi, Hiroshi, Satoshi Iwasaki, Yoshinori Takizawa, Yasuyuki Hashimoto, Kunihiro Mizuta, and Hiroyuki Mineta. "An Atypical Usher Syndrome Type 2 Patient with USH2A Mutations." Practica Oto-Rhino-Laryngologica 103, no. 5 (2010): 413–19. http://dx.doi.org/10.5631/jibirin.103.413.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Miner, Ilene. "The impact of Usher syndrome, type I, on adolescent development." Journal of Vocational Rehabilitation 6, no. 2 (1996): 159–66. http://dx.doi.org/10.3233/jvr-1996-6207.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Gerber, S., D. Larget-Piet, J. M. Rozet, D. Bonneau, M. Mathieu, V. Der Kaloustian, A. Munnich, and J. Kaplan. "Evidence for a fourth locus in Usher syndrome type I." Journal of Medical Genetics 33, no. 1 (January 1, 1996): 77–79. http://dx.doi.org/10.1136/jmg.33.1.77.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

van Aarem, Annelies, Cor W. R. J. Cremers, Alfred J. L. G. Pinckers, Patrick L. M. Huygen, Godfried C. J. H. Hombergen, and Bill J. Kimberling. "The Usher syndrome type 2A: clinical findings in obligate carriers." International Journal of Pediatric Otorhinolaryngology 31, no. 2-3 (March 1995): 159–74. http://dx.doi.org/10.1016/0165-5876(94)01081-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Murthy, Ramesh, and Santosh G. Honavar. "Secondary vasoproliferative retinal tumor associated with Usher syndrome type 1." Journal of American Association for Pediatric Ophthalmology and Strabismus 13, no. 1 (February 2009): 97–98. http://dx.doi.org/10.1016/j.jaapos.2008.07.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Iannaccone, Alessandro, Stephen B. Kritchevsky, Maria Laura Ciccarelli, Salvatore A. Tedesco, Claudio Macaluso, William J. Kimberling, and Grant W. Somes. "Kinetics of Visual Field Loss in Usher Syndrome Type II." Investigative Opthalmology & Visual Science 45, no. 3 (March 1, 2004): 784. http://dx.doi.org/10.1167/iovs.03-0906.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Well, Dominique, Stéphane Blanchard, Josseline Kaplan, Parry Guilford, Fernando Gibson, James Walsh, Philomena Mburu, et al. "Defective myosin VIIA gene responsible for Usher syndrome type IB." Nature 374, no. 6517 (March 1995): 60–61. http://dx.doi.org/10.1038/374060a0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Adato, Avital, Vincent Michel, Yoshiaki Kikkawa, Jan Reiners, Kumar N. Alagramam, Dominique Weil, Hiromichi Yonekawa, Uwe Wolfrum, Aziz El-Amraoui, and Christine Petit. "Interactions in the network of Usher syndrome type 1 proteins." Human Molecular Genetics 14, no. 3 (December 8, 2004): 347–56. http://dx.doi.org/10.1093/hmg/ddi031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Wagenaar, M., B. ter Rahe, A. van Aarem, P. Huygen, R. Admiraal, E. Bleeker-Wagemakers, A. Pinckers, W. Kimberling, and C. Cremers. "Clinical findings in obligate carriers of type I Usher syndrome." American Journal of Medical Genetics 59, no. 3 (November 20, 1995): 375–79. http://dx.doi.org/10.1002/ajmg.1320590319.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Vezinaw, Chloe M., Gerald A. Fishman, and John Chiang. "Unanticipated prognosis for a patient with type 2 Usher syndrome." Documenta Ophthalmologica 138, no. 2 (February 22, 2019): 161–66. http://dx.doi.org/10.1007/s10633-019-09677-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Larget-Piet, Dominique, Sylvie Gerber, Dominique Bonneau, Jean-Michel Rozet, Sophie Marc, Ihmad Ghazi, Jean-Louis Dufier, et al. "Genetic Heterogeneity of Usher Syndrome Type 1 in French Families." Genomics 21, no. 1 (May 1994): 138–43. http://dx.doi.org/10.1006/geno.1994.1235.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!